Orbitsymposium 2022

*Please note the schedule is subject to change.

08:00-08:50

Rapid fire 2

Chairpersons: Julian D Perry (USA) Raoul D Henson (Philippines) Hee Bae Ahn (Korea)

08:50-10:25

Infections or inflammatory
diseases

Chairpersons: Hirohiko Kakizaki (Japan) Ilse Mombaerts (Belgium) Sang In Khwang (Korea)

08:50-09:00	Rhino-orbito-cerebral mucormycosis: Dissimilar results from similar treatment?	Mohsen B Kashkouli (Iran)
09:00-09:10	Globe-sparing management of orbital mucormycosis	Bobby S Korn (USA)
09:10-09:20	Management algorithm in orbital inflammation: Our experience	Santosh G Honavar (India)
09:20-09:30	Evaluations and treatment of pediatric orbital inflammatory disease	Richard C Allen (USA)
09:30-09:40	Orbital myositis: A classification and review. The wide spectrum of associated systemic disease, drawing analogies with uveitis	Alan A McNab (Australia)
09:40-09:50	IgG4-related disease in multi-ethnic population	Vivian T Yin (Canada)
09:50-10:00	Update on orbital and adnexal granulomatosis with polyangiitis	Catherine J Hwang (USA)
10:00-10:10	Orbital xanthogranulomatous disease	Robert C Kersten (USA)
10:10-10:20	30 years of observations on silent sinus syndrome	John B Holds (USA)
10:20-10:25	Discussion

10:40-11:45

Orbital tumors 2

Chairpersons: Ashok K Grover (India) Geoffrey Rose (UK) Wha-Sun Chung (Korea)

10:40-10:50	Evolution of the precision care of optic nerve glioma	Michael Kazim (USA)
10:50-11:00	Optic pathway gliomas: A non-neurosurgical approach to debulking alone	William R Katowitz (USA)
11:00-11:10	A reclassification of periorbital neurofibromatosis and an algorithm of surgical management	Naresh Joshi (UK)
11:10-11:20	Enlarged one muscle: What we should know?	Kyung In Woo (Korea)
11:20-11:30	Orbital solitary fibrous tumors: What do we know?	Miguel Gonzalez-Candial (Spain)
11:30-11:40	CD34+ fibroblastic tumors of the orbit	Suk-Woo Yang (Korea)
11:40-11:45	Discussion

11:45-12:40

Recent advances in
orbital surgery

Chairpersons: Hunter K L Yuen (Hong Kong) Robert A Goldberg (USA) Sung Joo Kim (Korea)

11:45-11:55	3D printing technology for orbital wall reconstruction	Ho-Seok Sa (Korea)
11:55:12:05	Face transplantation for the orbital surgeon	Julian D Perry (USA)
12:05-12:15	Next generation orbitotomy and reconstruction	Kelvin Kam-Lung Chong (Hong Kong)
12:15-12:25	Techniques and applications for fat transfer to the orbit and periorbital region	Bradford W Lee (USA)
12:25-12:35	CUSA-assisted “inside out” removal of glioma	Guy Ben Simon (Israel)
12:35-12:40	Discussion

13:40-14:45

Thyroid eye disease 1 (medical)

Chairpersons: Gangadhara Sundar (Singapore) Terry J Smith (USA) Joo Heon Roh (Korea)

13:40-13:50	The fibrocyte plays villain and hero in thyroid eye disease	Terry J Smith (USA)
13:50-14:00	Novel biomarkers in thyroid eye disase	Jin Sook Yoon (Korea)
14:00-14:10	Radioactive iodine treatment and thyroid eye disease	Lay Leng Seah (Singapore)
14:10-14:20	Intraorbital injections in thyroid eye disease	Essam Eltoukhy (Egypt)
14:20-14:30	Thyroid eye disease with compressive optic neuropathy: Visual field loss classification and nomenclature	Suzanne K Freitag (USA)
14:30-14:40	Dysthyroid optic neuropathy	Peerooz Saeed (Netherlands)
14:40-14:45	Discussion

14:45-15:30

Thyroid eye disease 2 (surgical)

14:45-14:55	Indication and functional outcome of orbital decompression in thyroid eye disease	Christoph Hintschich (Germany)
14:55-15:05	Optimizing outcome of orbital decompression using stereotactic navigation	Reynaldo Javate (Philippines)
15:05-15:15	Deep lateral wall decompression with lateral rim removal	Marco Sales-Sanz (Spain)
15:15-15:30	Unbalanced orbital decompression	Milind Naik (India)

15:45-17:00

Orbital surgery from
different perspectives

Chairpersons: Dongmei Li (China) Jane Olver (UK) Sang Yeol Lee (Korea)

15:45-15:55	The management approaches to dacryoceles and their orbital expansion	Pelin Kaynak (Turkey)
15:55-16:05	Nasolacrimal Duct Obstruction in Patient with Meningoencephalocele: An Approach to Have A Successful Surgery	Yunia Irawati (Indonesia)
16:05-16:15	Transcaruncular approach for the management of orbital diseases	Shu Lang Liao (Taiwan)
16:15-16:25	Endonasal approach to orbital lesions	Dinesh Selva (Australia)
16:25-16:35	Endoscopic endonasal approach to various orbital lesions	Sang Duk Hong (Korea)
16:35-16:45	Endoscopic removal of small optic apical carvenous heamangioma	Wencan Wu (China)
16:45-16:55	360 degree circumferential endoscopic approaches to the orbital apex lesions	Doo-Sik Kong (Korea)
16:55-17:00	Discussion

17:00-17:55

Challenges and future in the
management of orbital diseases

Chairpersons: Chai Teck Choo (Singapore) Peter J Dolman (Canada) Hee-Young Choi (Korea)

17:00-17:10	Stem cell therapy in traumatic optic neuropathy	Helen Lew (Korea)
17:10-17:20	Patient specific implants in midface reconstruction	Michael P Grant (USA)
17:20-17:30	Immunotherapy in orbital metastasis	Alejandra Valenzuela (USA)
17:30-17:40	Targeted therapies in orbital disease	Timothy Sullivan (Austrailia)
17:40-17:50	Programmed cell death-ligand 1 (PD-L1) in orbital tumors	Diego Strianese (Italy)
17:50-17:55	Discussion

Orbitsymposium 2020